Figure 1.

Key efficacy endpoints showing statistical significance (P<0.1) of TOP1630 compared with placebo for DED (mean change from baseline to day 29, modified intention-to-treat population).

Note: See Results and Figures for data and further details.

Abbreviations: CAE, Controlled Adverse Environment; DED, dry eye disease.